Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.
about
Clinical Predictive Factors in Diabetic Kidney Disease ProgressionSecondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to GlomerulosclerosisRole of NADPH Oxidase in Metabolic Disease-Related Renal Injury: An UpdateDiabetic Kidney Disease: A Syndrome Rather Than a Single Disease.Association of Obesity and Kidney Function Decline among Non-Diabetic Adults with eGFR > 60 ml/min/1.73m(2): Results from the Multi-Ethnic Study of Atherosclerosis (MESA).Pathophysiology and treatment of focal segmental glomerulosclerosis: the role of animal models.Proximal tubular hypertrophy and enlarged glomerular and proximal tubular urinary space in obese subjects with proteinuria.Inflammation and oxidative stress in obesity-related glomerulopathyAdiponectin promotes functional recovery after podocyte ablation.Association between Obese Phenotype and Mildly Reduced eGFR among the General Population from Rural Northeast China.Is obesity a risk factor for chronic kidney disease in children?The prodromal phase of obesity-related chronic kidney disease: early alterations in cardiovascular and renal function in obese children and adolescents.Weight loss interventions and progression of diabetic kidney disease.Prevalence of hypertension and decreased glomerular filtration rate in obese children: results of a population-based field study.Urinary podocalyxin, the novel biomarker for detecting early renal change in obesity.Phenotypic characterization of a novel HO-1 depletion model in the rat.Increased urine podocyte-associated messenger RNAs in severe obesity are evidence of podocyte injury.The renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature.Genetic testing for podocyte genes in sporadic focal segmental glomerulosclerosis
P2860
Q26749494-E0476CF8-FFBE-4BDF-B32F-15BFB46E36D0Q26752830-5A5229F5-6451-4660-8DE4-D6592C7340B3Q28074668-B1B7C1EE-7253-45A5-A791-BAE057273E6FQ33583012-71E1DDD6-92BA-4AFB-896A-22BB9B5DB292Q34149313-3B257B2B-9E4F-4D2C-92CF-9CCF7F0458F2Q34645201-7BF5A11C-1105-467C-87DC-E11BEF0B7410Q35005734-8DB6267A-32AE-47BC-90E9-993CC24BCCAEQ35904102-33352B03-E396-4F5B-A311-7B95E55230BCQ36574746-C4CCC688-095C-487D-BF2B-646077083B12Q37044688-CB3A9E5D-492D-4CF3-B415-5A239F0BFDDEQ38059630-41270DB8-D2C2-4604-BEB0-11D7678FABFAQ38131465-2794A49E-0DFD-41D0-9F14-53DC5C56EC2CQ38539937-ECEA4269-E709-46B5-AB07-ECC609DFDD9DQ39321534-252DBBC6-9102-4A2C-9E36-CF47D394DB5AQ48196703-3CB7AC0D-86B2-4775-9BE2-E39B096AF170Q51364901-34479E70-D30E-41AE-BE45-6A276C3C167AQ53439401-52600AE0-628B-47BE-9407-93252E78A661Q53684500-A78DF0EB-0333-4588-B2BF-A52C8EDDEFD5Q58423175-F8A4305B-93F0-461C-AB40-F5E4963635E3
P2860
Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinicopathological characteri ...... segmental glomerulosclerosis.
@en
Clinicopathological characteri ...... segmental glomerulosclerosis.
@nl
type
label
Clinicopathological characteri ...... segmental glomerulosclerosis.
@en
Clinicopathological characteri ...... segmental glomerulosclerosis.
@nl
prefLabel
Clinicopathological characteri ...... segmental glomerulosclerosis.
@en
Clinicopathological characteri ...... segmental glomerulosclerosis.
@nl
P2093
P2860
P1476
Clinicopathological characteri ...... l segmental glomerulosclerosis
@en
P2093
Adel Kheder
Hédi Ben Maiz
Mohamed Habib Jaafoura
Rym Goucha
Sihem Darouich
P2860
P304
P356
10.3109/01913123.2011.584657
P50
P577
2011-06-09T00:00:00Z